Avery Dennison Corporation (AVY) Stock Price & Analysis
Avery Dennison Corporation (AVY) closed at USD 184.66 on Thursday, October 22, 2026, up 3.14% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 184.66; the Oct 22, 2026 session ranged USD 179.03–184.66 on volume of 984,566 shares. Market capitalization is —, with a 52-week range of USD 152.42–199.54 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:37 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AVY.md
Key facts (AVY)
- Last four reported quarters (through Jun 30, 2026): revenue $9.25B, net income $705M (7.6% margin), free cash flow $1.06B (SEC filings).
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $962K; 2 not under a Rule 10b5-1 plan ($962K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (11 analysts), mean target USD 199.5 (range 181–225).
- Total return with dividends: 1Y +1.4% vs S&P 500 +14.9%; 5Y -7.0% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 2.32, revenue estimate $2.26B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (AVY)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $8.41B | $9.04B | $8.36B | $8.76B | $8.86B | $9.25B |
| Gross profit | $2.31B | $2.40B | $2.28B | $2.53B | $2.55B | — |
| Net income | $740M | $757M | $503M | $705M | $688M | $705M |
| EPS (diluted) | $8.83 | $9.21 | $6.20 | $8.73 | $8.79 | — |
| Free cash flow | $792M | $683M | $561M | $730M | $712M | $1.06B |
| Gross margin | 27.5% | 26.6% | 27.2% | 28.9% | 28.8% | — |
| Net margin | 8.8% | 8.4% | 6.0% | 8.1% | 7.8% | 7.6% |
| Revenue growth | +20.6% | +7.5% | -7.5% | +4.7% | +1.1% | — |
| Cash + short-term investments | $163M | $167M | $215M | $377M | $252M | — |
| Total debt | $3.09B | $3.09B | $3.24B | $3.14B | $3.72B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (AVY)
P/E at fiscal year-ends: Dec 2025 20.7x, Dec 2024 21.4x, Dec 2023 32.6x.
Insider sales (SEC Form 4, open-market, last ~7 months) (AVY)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Colisto Nicholas | SVP & CIO | 3,886 | $663K | 35.3% | No | Too little history (no open-market trades in 2025) |
| 2026-08-04 | Walker Ignacio J | SVP and Chief Legal Officer | 1,742 | $299K | 17.5% | No | Too little history (no open-market trades in 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (AVY)
Consensus Buy (mean 2.00 on a 1–5 scale), 11 analysts; mean target USD 199.5 (low 181, high 225).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Truist Securities | Target lowered | Buy | $209 → $208 |
| 2026-07-31 | UBS | Target raised | Buy | $218 → $225 |
| 2026-07-31 | Citigroup | Target raised | Neutral | $184 → $186 |
| 2026-07-31 | JP Morgan | Target raised | Overweight | $185 → $190 |
| 2026-07-15 | Truist Securities | Target lowered | Buy | $221 → $209 |
| 2026-07-14 | B of A Securities | Target raised | Buy | $202 → $210 |
| 2026-07-09 | Citigroup | Target lowered | Neutral | $185 → $184 |
Total return (dividends reinvested) (AVY)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +1.4% | -7.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +1.4% | -1.4% |
| Volatility (annualized) | 23.6% | 22.2% |
| Max drawdown | -21.6% (Feb 2026→Jun 2026) | -30.8% (Nov 2021→Jun 2022) |
AVY revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Materials Group | $1.80B | 72.9% | +15.9% |
| Solutions Group | $666.8M | 27.1% | -0.5% |
| Total revenue | $2.46B | 100% | — |
AVY revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Apparel and other | $437.2M | 17.8% | +1.3% |
| Identification Solutions and Vestcom | $229.6M | 9.3% | -3.8% |
| Total revenue | $2.46B | 100% | — |
AVY revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $2.75B | 31.1% | +5.3% |
| Asia | $2.73B | 30.8% | -1.3% |
| Europe, the Middle East and North Africa | $2.46B | 27.7% | +1.6% |
| China Including Hong Kong | $1.35B | 15.2% | -3.6% |
| Latin America | $567.3M | 6.4% | -5.4% |
| Other International | $353.3M | 4.0% | -2.1% |
| Total revenue | $8.86B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
AVY suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Competitor | 3M (MMM) | “For graphics and reflective products, our largest competitors are 3M Company ("3M") and the Orafol Group.” |
Quoted from the company's 10-K filed Feb 25, 2026.
Companies that name AVY in their SEC reports
| Relationship to AVY | Company | Filing | Sentence |
|---|---|---|---|
| partner | TRANSACT TECHNOLOGIES INC (TACT) | 10-K Mar 12, 2026 | “Statement of Work (together with the License Agreement, the "Source Code Transition Agreement") with Avery Dennison.” |
| partner | Gauzy Ltd. (GAUZ) | 20-F Mar 11, 2025 | “entities affiliated with Ibex Israel Fund LLLP, Olive Tree V Limited Partnership, Infinity Holding Ventures PTE, Avery Dennison Israel” |
AVY company outlook (results filed Jul 30, 2026)
- “Based on the factors listed and other assumptions, the company expects full year 2026 reported EPS of $9.40 to $9.70.”
- “Excluding an estimated $0.60 per share impact of other items and restructuring charges, the company expects full year 2026 adjusted EPS of $10.00 to $10.30.”
Quoted word-for-word from the SEC 8-K results press release.
AVY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.32 | $2.49 | -6.8% | $2.26B | 10 |
| Next quarter (ends Dec 2026) | $2.49 | $2.57 | -3.3% | $2.32B | 10 |
| Current fiscal year (ends Dec 2026) | $10.18 | $10.02 | +1.6% | $9.34B | 11 |
| Next fiscal year (ends Dec 2027) | $11.19 | $11.10 | +0.8% | $9.64B | 11 |
AVY options: expected move
Options price a move of about ±7.1% (±$13.05) by Nov 20, 2026, which includes earnings on Oct 29, 2026. Over the last 8 reports the stock moved ±3.5% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 31.4% | ±7.1% |
| Dec 18, 2026 | 56 | 27.9% | ±8.8% |
| Jan 15, 2027 | 84 | 26.0% | ±10.0% |
| Apr 16, 2027 | 175 | 26.2% | ±14.4% |
30-day implied volatility 30.3% vs 18% realized over the last 30 trading days. Put/call ratio (volume) 0.21. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 10:37 UTC)
| Price | USD 184.66 |
|---|---|
| Change | ▲ 3.14% (up) |
| Previous Close | USD 184.66 |
| Open | USD 184.66 |
| Day Range | USD 179.03 – 184.66 |
| 52-Week Range | USD 152.42 – 199.54 |
| Volume | 984,566 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (AVY)
Nexqual's technical model rates AVY "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 10:37 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.77 (overbought) |
| vs SMA50 | Above (USD 173.89) |
| MACD | 2.1 (positive) |
Analyst Ratings (AVY)
Wall Street analysts rate AVY "Buy" based on 11 analysts, with a mean price target of USD 199.5 (range USD 181–225), per Nexqual as of October 23, 2026 at 10:37 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 199.5 |
| High Target | USD 225 |
| Low Target | USD 181 |
| Buy / Hold / Sell | 9 / 2 / 0 |
Earnings (AVY)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 2.32 |
| Revenue Estimate | $2.26B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.89 vs est 2.47 ▲ beat |
| 2026-03-31 | USD 2.47 vs est 2.43 ▲ beat |
| 2025-12-31 | USD 2.45 vs est 2.39 ▲ beat |
| 2025-09-30 | USD 2.37 vs est 2.33 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
Financials & Fundamentals (AVY)
| Total Revenue | $9.25B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +10.90% |
| Gross Margin | +28.98% |
| Operating Margin | +13.59% |
| Profit Margin | +7.62% |
| ROE | +31.16% |
| Debt / Equity | 1.59 |
| Current Ratio | 1.13 |
| Total Cash | $274.70M |
| Total Debt | $3.69B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.06B (11.5% of revenue) |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
Financial Health Score (AVY)
Nexqual rates Avery Dennison Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:37 UTC.
| Growth | Mixed — Revenue +1.1% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 29%, operating 14% (last 12 months) |
| Balance Sheet | Weak — $252M cash and investments vs $3.72B debt (Dec 2025, SEC) |
| Cash Flow | Solid — FCF $1.06B (last 4 quarters to Jun 2026, SEC), 11% margin |
| Efficiency | Strong — ROE 31%, ROA 8.4% |
Ownership (AVY)
| Insider Ownership | +0.64% |
|---|---|
| Institutional Ownership | +100.10% |
| Shares Outstanding | 75.79M |
| Float | 75.22M |
| Short % of Float | +3.02% |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
Leadership (AVY)
Avery Dennison Corporation is led by Deon M. Stander, President, CEO & Director, per Nexqual as of October 23, 2026 at 10:37 UTC.
| President, CEO & Director | Deon M. Stander |
|---|---|
| CFO, Senior VP & Principal Financial Officer | Gregory S. Lovins |
Major Backers & Investors (AVY)
Notable institutional backers of Avery Dennison Corporation include Wellington Management, Morgan Stanley, Ameriprise Financial, Inc., according to Nexqual as of October 23, 2026 at 10:37 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 7.64% |
| Morgan Stanley | 4.68% |
| Ameriprise Financial, Inc. | 3.03% |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 2.1% |
| Invesco | 2.06% |
| Price (T.Rowe) Associates Inc | 1.99% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 13.02% |
| BlackRock | 8.55% |
| State Street | 5.34% |
| Geode Capital | 2.87% |
Source: Nexqual, October 23, 2026 at 10:37 UTC.
From Avery Dennison Corporation's Latest SEC 10-K Filing (filed 2026-02-25)
Key Strengths & Strategy (as disclosed to the SEC)
- Our decades of experience creating solutions for customers and our deep expertise enable us to bring innovative solutions to the industries we serve.
- We have developed adhesives and adhesive processing systems that minimize the use of solvents.
Legal & Regulatory Risks (Item 1A, quoted)
- We also have valuable intellectual property upon which third parties may infringe.
- Unfavorable developments in legal proceedings, investigations and other legal and regulatory matters, could impact us in a materially adverse manner.
- We are required to comply with anti-corruption and other compliance laws and regulations of the U.S. government and various international jurisdictions, and our failure to comply with these laws and regulations could have a material adverse effect on our business.
- We are subject to export and import control laws and regulations in the jurisdictions in which we do business that could subject us to liability or impair our ability to compete in these markets.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCK | Crown Holdings, Inc. | USD 119.26 | ▲ 2.62% |
| BALL | Ball Corporation | USD 65.81 | ▲ 2.59% |
| IP | International Paper Company | USD 33.68 | ▲ 0.15% |
| AMCR | Amcor plc | USD 46.28 | ▲ 2.23% |
| SW | Smurfit WestRock plc | USD 42.43 | ▲ 2.34% |
| PKG | Packaging Corporation of Americ | USD 248.92 | ▲ 4.15% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:37 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt